Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence N Shulman

Showing results (81-90 of 216) with videos related to

Pageof 22
Sort By:
Cancer|March 15, 2012
Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B ExperienceJeffrey Peppercorn, Iuliana Shapira, Teressa Deshields, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2019
Establishing effective patient navigation programs in oncologyDiego Lopez, Mandi L Pratt-Chapman, Elizabeth A Rohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trialJennifer R Bellon, Steven E Come, Rebecca S Gelman, et al.
Bulletin of the World Health Organization|January 3, 2023
Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert<sup>®</sup> mRNA expression assayParsa Erfani, Esther Gaga, Emmanuel Hakizimana, et al.
JCO Global Oncology|May 18, 2022
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant ChemotherapyYehoda M Martei, Mohan Narasimhamurthy, Dipho I Setlhako, et al.
American Journal of Clinical Oncology|December 15, 2004
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumorsA David McCollum, Matthew H Kulke, David P Ryan, et al.
The Oncologist|May 10, 2021
Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited ContextRebecca J DeBoer, Espérance Mutoniwase, Cam Nguyen, et al.
The American Journal of Surgical Pathology|November 10, 2009
Partners in pathology: a collaborative model to bring pathology to resource poor settingsJoseph W Carlson, Evan Lyon, David Walton, et al.
JCO Global Oncology|November 5, 2020
Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast CancerTemidayo Fadelu, Ruth Damuse, Joarly Lormil, et al.
Investigational New Drugs|March 9, 2007
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactionsNancy U Lin, Leroy M Parker, Steven E Come, et al.
Pageof 22

Showing results (81-90 of 216) with videos related to

Sort By:
Pageof 22
Cancer|March 15, 2012
Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B ExperienceJeffrey Peppercorn, Iuliana Shapira, Teressa Deshields, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 20, 2019
Establishing effective patient navigation programs in oncologyDiego Lopez, Mandi L Pratt-Chapman, Elizabeth A Rohan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trialJennifer R Bellon, Steven E Come, Rebecca S Gelman, et al.
Bulletin of the World Health Organization|January 3, 2023
Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert<sup>®</sup> mRNA expression assayParsa Erfani, Esther Gaga, Emmanuel Hakizimana, et al.
JCO Global Oncology|May 18, 2022
Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant ChemotherapyYehoda M Martei, Mohan Narasimhamurthy, Dipho I Setlhako, et al.
American Journal of Clinical Oncology|December 15, 2004
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumorsA David McCollum, Matthew H Kulke, David P Ryan, et al.
The Oncologist|May 10, 2021
Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited ContextRebecca J DeBoer, Espérance Mutoniwase, Cam Nguyen, et al.
The American Journal of Surgical Pathology|November 10, 2009
Partners in pathology: a collaborative model to bring pathology to resource poor settingsJoseph W Carlson, Evan Lyon, David Walton, et al.
JCO Global Oncology|November 5, 2020
Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast CancerTemidayo Fadelu, Ruth Damuse, Joarly Lormil, et al.
Investigational New Drugs|March 9, 2007
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactionsNancy U Lin, Leroy M Parker, Steven E Come, et al.
Pageof 22